PHARMACYTE BIOTECH, INC. Convertible Preferred Stock, Shares Issued upon Conversion
PHARMACYTE BIOTECH, INC. (PMCB) had Convertible Preferred Stock, Shares Issued upon Conversion of 888.89 thousand shares as of 2011-04-30, per its 10-K filed 2013-07-29.
Discontinued › Notes › Equity
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2013-07-29
- 2011-04-30: Convertible Preferred Stock, Shares Issued upon Conversion 888.89K shares; Convertible Preferred Stock, Shares Issued upon Conversion as first filed 2.67M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion | Convertible Preferred Stock, Shares Issued upon Conversion as first filed |
|---|---|---|
| 2011-04-30 | 888.89K shares 10-K · filed 2013-07-29 | 2.67M shares 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |